• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 471654 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1413803431 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1413803431 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Shares of Illumina Receive a Boost, Up 1.2%

Published on Thu, 04/04/2013 - 10:28
By Robert Cotter

Illumina (NASDAQ:ILMN), a company whose shares are moving quickly, is trading 1.2% higher to $54.94. The S&P is currently trading 0.3% higher to 1,558 and the Dow Jones Industrial Average is trading 0.2% higher to 14,586.

Illumina share prices have moved between a 52-week high of $79.40 and a 52-week low of $25.57 and are now trading 115% above that low price at $54.94 per share. The 200-day and 50-day moving averages have moved 0.47% higher and 0.38% higher over the past week, respectively.

There is potential upside of 0.2% for shares of Illumina based on a current price of $54.94 and an average consensus analyst price target of $55.07. The stock should discover initial support at its 50-day moving average (MA) of $51.56 and subsequent support at its 200-day MA of $48.01.

Illumina, Inc. develops, manufactures and markets integrated systems for the large scale analysis of genetic variation and biological function. The Company provides a comprehensive line of products and services that currently serve the sequencing, genotyping and gene expression markets for genomic research centers, pharmaceutical companies, academic institutions and biotechnology companies.

By Robert Cotter
rcotter@fnno.com

Latest News from FNNO

McCormick & Co Earnings Hindsight: Down ...

When McCormick & Co (NYSE:MKC) reported earnings two weeks ago on October 2nd, 2014, an ...

Shares of Strayer Education Have Risen A...

Shares of Strayer Education (NASDAQ:STRA) traded today at $64.79, breaking its 52-week ...

Shares of Sonic Rise Above Previous 52-W...

Shares of Sonic (NASDAQ:SONC) traded today at $23.96, breaking its 52-week high. So fa ...

Shares of Sciclone Pharmaceuticals Rise ...

Shares of Sciclone Pharmaceuticals (NASDAQ:SCLN) traded at a new 52-week high today of ...

Shares of Regeneron Pharmaceuticals Rise...

Regeneron Pharmaceuticals (NASDAQ:REGN) traded today at a new 52-week high of $376.88. ...

Shares of RadNet Have Risen Above Previo...

Shares of RadNet (NASDAQ:RDNT) traded at a new 52-week high today of $8.72. Approximat ...

Recent 52-Week High Exceeded in Shares o...

The Pantry (NASDAQ:PTRY) traded today at a new 52-week high of $24.55. So far today ap ...

Nestle Looks to Continue to Trade Below ...

Shares of Nestle (NASDAQ:NSRGY) traded today at $65.79, breaking its 52-week low. This ...